NewAmsterdam Pha Financials
This page shows NewAmsterdam Pha (NAMSW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cash, not revenue, is carrying this business: a large equity-funded R&D program dominates a still-small commercial base.
Across FY2024 and FY2025, operating cash burn stayed near$150M even as net loss remained above$200M , so the accounting deficit is not the best guide to runway. What matters more is that FY2025 still ended with$490M of cash against only$85.9M of liabilities, showing a business funded mainly by prior equity raises rather than creditor support.
This is a development-stage cost structure: FY2025 R&D spending of
The balance sheet became less flush in FY2025 as cash fell from
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of NewAmsterdam Pha's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
NewAmsterdam Pha passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, NewAmsterdam Pha generates $0.73 in operating cash flow (-$147.8M OCF vs -$203.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
NewAmsterdam Pha generated $22.5M in revenue in fiscal year 2025. This represents a decrease of 50.6% from the prior year.
NewAmsterdam Pha's EBITDA was -$225.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 28.0% from the prior year.
NewAmsterdam Pha reported -$203.0M in net income in fiscal year 2025. This represents an increase of 16.1% from the prior year.
NewAmsterdam Pha earned $-1.72 per diluted share (EPS) in fiscal year 2025. This represents an increase of 32.8% from the prior year.
Cash & Balance Sheet
NewAmsterdam Pha generated -$148.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 7.0% from the prior year.
NewAmsterdam Pha held $490.0M in cash against $0 in long-term debt as of fiscal year 2025.
NewAmsterdam Pha had 115M shares outstanding in fiscal year 2025. This represents an increase of 6.4% from the prior year.
Margins & Returns
NewAmsterdam Pha's operating margin was -1002.9% in fiscal year 2025, reflecting core business profitability. This is down 616.0 percentage points from the prior year.
NewAmsterdam Pha's net profit margin was -902.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 371.0 percentage points from the prior year.
NewAmsterdam Pha's ROE was -29.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.3 percentage points from the prior year.
Capital Allocation
NewAmsterdam Pha invested $141.8M in research and development in fiscal year 2025. This represents a decrease of 6.3% from the prior year.
NewAmsterdam Pha invested $246K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 63.4% from the prior year.
NAMSW Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0M+9400.0% | $32K-90.8% | $348K-98.2% | $19.1M+542.9% | $3.0M-76.7% | $12.8M-56.1% | $29.1M+1177.4% | $2.3M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $38.0M-1.5% | $38.6M+24.6% | $31.0M+12.6% | $27.5M-38.5% | $44.8M+28.2% | $34.9M-2.3% | $35.7M-7.0% | $38.4M |
| SG&A Expenses | $23.5M-14.5% | $27.4M+11.8% | $24.5M-10.1% | $27.3M+0.4% | $27.2M+28.6% | $21.1M+14.6% | $18.4M+11.8% | $16.5M |
| Operating Income | -$58.4M+11.5% | -$66.0M-19.7% | -$55.1M-54.7% | -$35.6M+48.3% | -$68.9M-59.4% | -$43.2M-72.9% | -$25.0M+52.4% | -$52.6M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | -$1K | N/A |
| Net Income | -$48.4M+34.6% | -$74.1M-2.9% | -$72.0M-314.7% | -$17.4M+56.1% | -$39.5M+57.3% | -$92.6M-456.1% | -$16.6M+57.3% | -$39.0M |
| EPS (Diluted) | $-0.40 | N/A | $-0.61-306.7% | $-0.15+55.9% | $-0.34 | N/A | $-0.18+56.1% | $-0.41 |
NAMSW Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $732.6M-4.8% | $769.3M-2.2% | $786.4M-3.5% | $815.1M-0.4% | $818.4M-5.3% | $864.6M+96.9% | $439.2M-1.7% | $446.7M |
| Current Assets | $658.0M-2.6% | $675.7M-7.7% | $732.3M-4.9% | $769.9M-5.8% | $817.3M-5.3% | $863.4M+97.2% | $437.9M-1.7% | $445.4M |
| Cash & Equivalents | $457.6M-6.6% | $490.0M-9.0% | $538.4M-4.5% | $563.9M-24.7% | $748.4M-3.0% | $771.7M+82.6% | $422.7M-1.9% | $430.7M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $67.4M-21.5% | $85.9M+47.1% | $58.4M+59.4% | $36.6M-10.8% | $41.0M-61.7% | $107.1M+77.6% | $60.3M+1.8% | $59.3M |
| Current Liabilities | $67.4M-21.4% | $85.8M+47.2% | $58.3M+59.6% | $36.5M-10.8% | $40.9M-61.7% | $106.9M+159.2% | $41.3M-8.9% | $45.3M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $665.2M-2.7% | $683.4M-6.1% | $728.1M-6.5% | $778.5M+0.1% | $777.4M+2.6% | $757.5M+99.9% | $378.9M-2.2% | $387.4M |
| Retained Earnings | -$810.8M-6.4% | -$762.4M-10.9% | -$687.5M-11.7% | -$615.5M-2.9% | -$598.1M-7.1% | -$558.6M-19.8% | -$466.4M-3.7% | -$449.7M |
NAMSW Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$30.6M+25.1% | -$40.9M-24.7% | -$32.8M+13.0% | -$37.7M-3.3% | -$36.5M+2.7% | -$37.5M-199.8% | -$12.5M+76.8% | -$54.0M |
| Capital Expenditures | $38K-62.0% | $100K+138.1% | $42K-52.3% | $88K+450.0% | $16K+433.3% | $3K-96.0% | $75K-64.1% | $209K |
| Free Cash Flow | -$30.6M+25.2% | -$41.0M-24.9% | -$32.8M+13.1% | -$37.8M-3.5% | -$36.5M+2.7% | -$37.5M-198.0% | -$12.6M+76.8% | -$54.2M |
| Investing Cash Flow | -$11.5M+45.6% | -$21.1M-943.6% | $2.5M+101.6% | -$159.1M-5673.9% | $2.9M+104.6% | -$62.2M-82805.3% | -$75K+64.1% | -$209K |
| Financing Cash Flow | $11.1M-19.1% | $13.7M+132.2% | $5.9M+72.0% | $3.4M-47.5% | $6.5M-98.6% | $456.6M+787160.3% | $58K-98.8% | $4.7M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NAMSW Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -1921.7%+204265.8pp | -206187.5%-190341.8pp | -15845.7%-15659.6pp | -186.1%+2128.3pp | -2314.5%-1976.0pp | -338.5%-252.6pp | -85.9%+2221.0pp | -2306.9% |
| Net Margin | -1593.5%+229981.6pp | -231575.0%-210883.9pp | -20691.1%-20600.4pp | -90.7%+1236.6pp | -1327.3%-602.4pp | -724.9%-667.7pp | -57.2%+1654.4pp | -1711.6% |
| Return on Equity | -7.3%+3.6pp | -10.8%-1.0pp | -9.9%-7.7pp | -2.2%+2.8pp | -5.1%+7.1pp | -12.2%-7.8pp | -4.4%+5.7pp | -10.1% |
| Return on Assets | -6.6%+3.0pp | -9.6%-0.5pp | -9.2%-7.0pp | -2.1%+2.7pp | -4.8%+5.9pp | -10.7%-6.9pp | -3.8%+4.9pp | -8.7% |
| Current Ratio | 9.76+1.9 | 7.88-4.7 | 12.57-8.5 | 21.08+1.1 | 19.98+11.9 | 8.08-2.5 | 10.61+0.8 | 9.83 |
| Debt-to-Equity | 0.10-0.0 | 0.13+0.0 | 0.08+0.0 | 0.050.0 | 0.05-0.1 | 0.14-0.0 | 0.160.0 | 0.15 |
| FCF Margin | -1008.0%+127038.9pp | -128046.9%-118618.4pp | -9428.4%-9231.2pp | -197.2%+1027.9pp | -1225.1%-931.6pp | -293.5%-250.3pp | -43.2%+2334.5pp | -2377.7% |
Similar Companies
Frequently Asked Questions
What is NewAmsterdam Pha's annual revenue?
NewAmsterdam Pha (NAMSW) reported $22.5M in total revenue for fiscal year 2025. This represents a -50.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is NewAmsterdam Pha's revenue growing?
NewAmsterdam Pha (NAMSW) revenue declined by 50.6% year-over-year, from $45.6M to $22.5M in fiscal year 2025.
Is NewAmsterdam Pha profitable?
No, NewAmsterdam Pha (NAMSW) reported a net income of -$203.0M in fiscal year 2025, with a net profit margin of -902.1%.
What is NewAmsterdam Pha's EBITDA?
NewAmsterdam Pha (NAMSW) had EBITDA of -$225.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is NewAmsterdam Pha's operating margin?
NewAmsterdam Pha (NAMSW) had an operating margin of -1002.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is NewAmsterdam Pha's net profit margin?
NewAmsterdam Pha (NAMSW) had a net profit margin of -902.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is NewAmsterdam Pha's return on equity (ROE)?
NewAmsterdam Pha (NAMSW) has a return on equity of -29.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is NewAmsterdam Pha's free cash flow?
NewAmsterdam Pha (NAMSW) generated -$148.0M in free cash flow during fiscal year 2025. This represents a 7.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is NewAmsterdam Pha's operating cash flow?
NewAmsterdam Pha (NAMSW) generated -$147.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are NewAmsterdam Pha's total assets?
NewAmsterdam Pha (NAMSW) had $769.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What are NewAmsterdam Pha's capital expenditures?
NewAmsterdam Pha (NAMSW) invested $246K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does NewAmsterdam Pha spend on research and development?
NewAmsterdam Pha (NAMSW) invested $141.8M in research and development during fiscal year 2025.
What is NewAmsterdam Pha's current ratio?
NewAmsterdam Pha (NAMSW) had a current ratio of 7.88 as of fiscal year 2025, which is generally considered healthy.
What is NewAmsterdam Pha's debt-to-equity ratio?
NewAmsterdam Pha (NAMSW) had a debt-to-equity ratio of 0.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is NewAmsterdam Pha's return on assets (ROA)?
NewAmsterdam Pha (NAMSW) had a return on assets of -26.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is NewAmsterdam Pha's cash runway?
Based on fiscal year 2025 data, NewAmsterdam Pha (NAMSW) had $490.0M in cash against an annual operating cash burn of $147.8M. This gives an estimated cash runway of approximately 40 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is NewAmsterdam Pha's Piotroski F-Score?
NewAmsterdam Pha (NAMSW) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are NewAmsterdam Pha's earnings high quality?
NewAmsterdam Pha (NAMSW) has an earnings quality ratio of 0.73x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is NewAmsterdam Pha?
NewAmsterdam Pha (NAMSW) scores 66 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.